Profile Image

Professor Darren Shafren

Professor

School of Biomedical Sciences and Pharmacy (Immunology and Microbiology)

Career Summary

Biography

Research Expertise
- Virology and Oncolytic Virotherapy. - The molecular biology of picornaviruses, and the potential use of viruses as anti-cancer agents.

Qualifications

  • PhD, University of Newcastle
  • Bachelor of Science (Honours), University of Newcastle

Keywords

  • Carcinogenesis
  • Microbiology
  • Oncology
  • Oncolytic Virotherapy
  • Virology

Fields of Research

Code Description Percentage
030499 Medicinal and Biomolecular Chemistry not elsewhere classified 15
110399 Clinical Sciences not elsewhere classified 35
111299 Oncology and Carcinogenesis not elsewhere classified 50

Professional Experience

UON Appointment

Title Organisation / Department
Professor University of Newcastle
School of Biomedical Sciences and Pharmacy
Australia

Awards

Recipient

Year Award
1998 HMRI Young Medical Researcher of the Year
Unknown
1998 HMRI Young Medical Researcher of the Year
Unknown
1998 HMRI Young Medical Researcher of the Year
Unknown

Invitations

Participant

Year Title / Rationale
2005 3rd International Conference on Oncolytic Viruses as Cancer Therapeutics
Organisation: Mayo Clinic
2005 3rd International Conference on Oncolytic Viruses as Cancer Therapeutics
Organisation: Mayo Clinic
2005 3rd International Conference on Oncolytic Viruses as Cancer Therapeutics
Organisation: Mayo Clinic
Edit

Research Supervision

Number of supervisions

Completed10
Current0

Past Supervision

Year Level of Study Research Title Program Supervisor Type
2018 PhD Investigation of Coxsackievirus A21 as a Potential Treatment for Pancreatic Cancer PhD (Immunology & Microbiol), Faculty of Health and Medicine, The University of Newcastle Co-Supervisor
2016 PhD Investigation of Oncolytic Coxsackievirus A21 as a Potential Treatment for Lung Cancer PhD (Immunology & Microbiol), Faculty of Health and Medicine, The University of Newcastle Co-Supervisor
2016 PhD Enhancement of Oncolytic Coxsackievirus A21 with Conventional Chemotherapies and Immune Checkpoint Inhibitors for the Treatment of Melanoma PhD (Immunology & Microbiol), Faculty of Health and Medicine, The University of Newcastle Co-Supervisor
2014 PhD Low Pathogenic Human Enteroviruses as Novel Anti-Cancer Agents Against Malignant Glioma PhD (Immunology & Microbiol), Faculty of Health and Medicine, The University of Newcastle Co-Supervisor
2009 PhD Enteroviral-Mediated Oncolysis of Cancer: Evaluation of Efficacy and Obstacles to Therapeutic Success PhD (Immunology & Microbiol), Faculty of Health and Medicine, The University of Newcastle Principal Supervisor
2009 PhD Enteroviruses as Novel Oncolytic Agents for the Control of Human Prostate Cancer PhD (Immunology & Microbiol), Faculty of Health and Medicine, The University of Newcastle Principal Supervisor
2008 PhD Viral Oncolysis of Human Breast Cancer PhD (Immunology & Microbiol), Faculty of Health and Medicine, The University of Newcastle Principal Supervisor
2005 PhD Control of Cancer Progression by Virotherapy PhD (Immunology & Microbiol), Faculty of Health and Medicine, The University of Newcastle Principal Supervisor
2003 PhD Mechanisms of Cell Entry and Release of Coxsackievirus B3 (CVB3) PhD (Immunology & Microbiol), Faculty of Health and Medicine, The University of Newcastle Sole Supervisor
2003 PhD Cellular Receptor Interactions of C Cluster Coxsackie A Viruses PhD (Immunology & Microbiol), Faculty of Health and Medicine, The University of Newcastle Principal Supervisor
Edit

Research Collaborations

The map is a representation of a researchers co-authorship with collaborators across the globe. The map displays the number of publications against a country, where there is at least one co-author based in that country. Data is sourced from the University of Newcastle research publication management system (NURO) and may not fully represent the authors complete body of work.

Country Count of Publications
Australia 47
United Kingdom 6
Sweden 6
United States 5
American Samoa 1
More...
Edit

News

Historic buyout signals promising hope for global cancer therapy

June 29, 2018

World-leading pharmaceutical company MSD (Merck in the US), has acquired virotherapy firm, Viralytics, founded in Newcastle by Associate Professor Darren Shafren.

UON biotech startup sells for $502 million

February 23, 2018

Oncolytic virotherapy firm Viralytics, which originated from the work of UON's Associate Professor Darren Shafren, has been acquired for $502 million by world-leading pharmaceutical company, Merck.

Cancer therapy secures $27.1m funding

January 31, 2014

Viralytics announces $27.1m for completion of international trials of CAVATAK

Professor Darren Shafren

Position

Professor
School of Biomedical Sciences and Pharmacy
Faculty of Health and Medicine

Focus area

Immunology and Microbiology

Contact Details

Email darren.shafren@newcastle.edu.au
Phone (02) 4913 8158
Fax (02) 4913 8814

Office

Room DMB305
Building David Maddison Clinical Sciences Building
Location David Maddison Clinical Sciences Building

,
Edit